Arcillas, Eduardo R.

HRN: 27-10-12  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2025
CEFTRIAXONE 1G (VIAL)
07/13/2025
07/20/2025
IV
1g
Q12
Ascending Colon Mass
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines